Evaluation of Health-Related Values and Preferences of Adults Who Were Preterm Infants and Parents of Preterm Infants Concerning Use of Prophylactic Cyclooxygenase Inhibitor Drugs
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.2273
Abstract: Key Points Question What are the values and preferences of parents of preterm infants and adults who had been born preterm concerning the use of cyclooxygenase inhibitor (COX-I) prophylaxis to prevent morbidity and mortality? Findings… read more here.
Keywords: parents preterm; concerning use; values preferences; cyclooxygenase inhibitor ... See more keywords
Editor's Note: From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer research"
DOI: 10.1158/0008-5472.can-19-0502
Abstract: The editors are publishing this note to alert the readers to a concern about [this article][1] ([1][2]). The editors were made aware of apparent splicing between Western blot lanes 3 and 4 in Fig. 7B.… read more here.
Keywords: novel class; cyclooxygenase inhibitor; editor note; inhibitor celecoxib ... See more keywords
Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?
Sign Up to like & getrecommendations! Published in 2019 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s188583
Abstract: Purpose This study aimed to investigate the role of a cyclooxygenase inhibitor in ovarian hyperstimulation syndrome (OHSS) treatment and compare it with cabergoline. Materials and methods A total of 32 immature female Wistar albino rats… read more here.
Keywords: ovarian hyperstimulation; cyclooxygenase inhibitor; treatment; group ... See more keywords
Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.637504
Abstract: The clinical application of immunotherapy is the milestone of cancer treatment. However, some patients have bad reaction. Cyclooxygenase-2 (COX-2) is frequently expressed in multiple cancer cells and is associated with poor prognosis. It is the… read more here.
Keywords: cancer; cyclooxygenase inhibitor; inhibitor potential; immunotherapy ... See more keywords